J Lopez

发表

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol‐Lowering Treatment (ADCLT) trial

D L Sparks, D. Sparks, D. Connor, 2006, Acta neurologica Scandinavica. Supplementum.